Business Paid
EBRD supports Poland’s Polpharma
22:58
The European Bank for Reconstruction and Development (EBRD) is providing Polish largest pharmaceuticals producer Polpharma with a PLN 200 million (€45 million equivalent) loan for general and corporate purposes including in-house R&D activities, green investments, and ESG strategy.
Investment in new technologies will unlock the development of new substances and products in currently unavailable niches. The EBRD loan will also be used for the implementation of a “Go green” modernization program…
This article is for subscribers
Warsaw Business Journal subscribers get the full archive (12,248 articles going back to 1995) and the print edition.
SubscribeOr try Poland A.M. free for 7 days, the daily briefing, or see all plans and prices.
